March 24, 2008
March 3, 2008
Important scientific innovation rarely makes its way by gradually winning over and converting its opponents: it rarely happens that Saul becomes Paul. What does happen is that its opponents gradually die out and that the growing generation is familiarized with the idea from the beginning.
Max Planck
When I was a graduate student at Cambridge, the confluence of great ideas and copious amounts of beer tended to produce a more nerdy brand of graffiti. Here is a photo I took of the street outside The Eagle (famous as the pub that Watson and Crick frequented).

When I was a graduate student at Cambridge, the confluence of great ideas and copious amounts of beer tended to produce a more nerdy brand of graffiti. Here is a photo I took of the street outside The Eagle (famous as the pub that Watson and Crick frequented).

CALL FOR PAPERS: The 4th Philippine Biotechnology Venture Summit

4th Annual PHILIPPINE BIOTECHNOLOGY VENTURE SUMMIT
The Premiere and Pioneering Conference on Biotechnology Enterprise and Investment
Auditorium, Ateneo School of Medicine and Public Health,
Don Eugenio Lopez Sr. Medical Complex, Ortigas Avenue, Pasig
April 16 to 18, 2008 


Hybridigm Consulting , the first biotechnology consultancy firm in the country, proudly presents the Philippine Biotech Venture Summit: The 4th Annual Conference on Biotechnology Enterprise and Investment. The Summit’s primary objective is to promote the advancement and better understanding of Biotechnology in the Philippines by calling together Philippine Scientists, Academics , Regulators, Policy Formulators, Venture Capitalists, and Mainstream businessmen to discuss new trends, discoveries and business opportunities. This 3-day summit aims to educate scientists, entrepreneurs, investors, managers in pharmaceutical firms, policy makers, as well as corporate and intellectual property lawyers.


CALL FOR PAPERS
Interested participants are invited to submit their papers for poster or oral presentations. These papers must encapsulate research whose findings can be developed into a marketable product or service within the next three (3) years, given additional funding for scale-up, prototyping, or development. The extended abstract should include a section on the potential market for the technology and a line budget for the development work required; aside from the typical IMRAD format of academic papers.


FIELDS OF INTEREST:
·        Medical Biotechnology
·        Bioinformatics
·        Diagnostics
·        Natural Ingredients or Natural Products
·        Bioengineering
·        Medical Devices


FORMAT:
·        MS Word (.doc) format written in English on an A4 (8.27” x 11.69”) template with a 1” margin on all sides.
·        Text should be 12-point Arial, single-spaced and justified paragraphs
·        Title of the paper should be in bold-faced capital letters and centered
·        Name of the author(s) centered and two-line spaces from the title; presenter’s name should be underlined
·        Author(s) affiliation are centered and one line space from the name of the author(s)
·        No more than four (4) pages including figures, tables, and references.


Send extended abstracts via email as Word (.doc) not later than 15 March 2008 by email to:
Joy Charisse O. Bulan
Junior Consultant, Hybridigm Consulting
tel: 8138412 | fax: 8108639 | email: jc.bulan@hybridigm-consulting.com


Authors of accepted papers will be notified not later than 24 March 2008. Only papers of authors who register by 31 March 2008 will be included in the program.